Purple Innovation (PRPL) Tops Q1 EPS by 7c, Revenues Beat; Raises FY21 Revenues Mid-Point Guidance Above Consensus, 2Q Revs. View Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Purple Innovation (PRPL) Prices 7.308M Shares Secondary Offering at $30/Sh
May 19, 2021 5:48 AM EDTPurple Innovation, Inc. (NASDAQ: PRPL), a leader in comfort innovation and the creator of the renowned Purple® Mattress, today announced the pricing of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The shares of Class A common stock are being sold at a price of... More
Purple Innovation (PRPL) Announces Proposed 7.309M Share Secondary Offering
May 18, 2021 4:37 PM EDTPurple Innovation, Inc. (NASDAQ: PRPL), a leader in comfort innovation and the creator of the renowned Purple® Mattress, today announced the launch of an underwritten secondary public offering of 7,308,792 shares of its Class A common stock to be sold by Coliseum Capital Partners, L.P., Coliseum Co-Invest Debt Fund, L.P., Blackwell Partners LLC Series A, and Coliseum Capital Co-Invest III, L.P. (collectively, the "Selling Stockholders"). The underwriters have a 30-day option period to purchase up to 1,096,318... More

